Glyscend's Incubator/Accelerator Round

Glyscend raised a round of funding on May 01, 2018. Investors include JLabs.

Glyscend is developing an approach to treating type 2 diabetes by recreating the effects of bariatric surgery, like gastric bypass, for diabetes and obesity without the need for invasive procedures.…

Articles about Glyscend's Incubator/Accelerator Round: